450 related articles for article (PubMed ID: 21255407)
1. Cross-talk between cd1d-restricted nkt cells and γδ cells in t regulatory cell response.
Liu W; Huber SA
Virol J; 2011 Jan; 8():32. PubMed ID: 21255407
[TBL] [Abstract][Full Text] [Related]
2. γδ T lymphocytes kill T regulatory cells through CD1d.
Huber SA
Immunology; 2010 Oct; 131(2):202-9. PubMed ID: 21050191
[TBL] [Abstract][Full Text] [Related]
3. Cross-regulation of T regulatory-cell response after coxsackievirus B3 infection by NKT and γδ T cells in the mouse.
Liu W; Moussawi M; Roberts B; Boyson JE; Huber SA
Am J Pathol; 2013 Aug; 183(2):441-9. PubMed ID: 23746656
[TBL] [Abstract][Full Text] [Related]
4. Defining a novel subset of CD1d-dependent type II natural killer T cells using natural killer cell-associated markers.
Singh AK; Rhost S; Löfbom L; Cardell SL
Scand J Immunol; 2019 Sep; 90(3):e12794. PubMed ID: 31141185
[TBL] [Abstract][Full Text] [Related]
5. The Role of Adaptor Proteins in the Biology of Natural Killer T (NKT) Cells.
Gerth E; Mattner J
Front Immunol; 2019; 10():1449. PubMed ID: 31293596
[TBL] [Abstract][Full Text] [Related]
6. Type II NKT cells: a distinct CD1d-restricted immune regulatory NKT cell subset.
Dasgupta S; Kumar V
Immunogenetics; 2016 Aug; 68(8):665-76. PubMed ID: 27405300
[TBL] [Abstract][Full Text] [Related]
7. Vγ4 γδ T cell-derived IL-17A negatively regulates NKT cell function in Con A-induced fulminant hepatitis.
Zhao N; Hao J; Ni Y; Luo W; Liang R; Cao G; Zhao Y; Wang P; Zhao L; Tian Z; Flavell R; Hong Z; Han J; Yao Z; Wu Z; Yin Z
J Immunol; 2011 Nov; 187(10):5007-14. PubMed ID: 21987663
[TBL] [Abstract][Full Text] [Related]
8. Vgamma4(+) T cells promote autoimmune CD8(+) cytolytic T-lymphocyte activation in coxsackievirus B3-induced myocarditis in mice: role for CD4(+) Th1 cells.
Huber SA; Sartini D; Exley M
J Virol; 2002 Nov; 76(21):10785-90. PubMed ID: 12368321
[TBL] [Abstract][Full Text] [Related]
9. Type II Natural Killer T Cells Contribute to Protection Against Systemic Methicillin-Resistant
Genardi S; Visvabharathy L; Cao L; Morgun E; Cui Y; Qi C; Chen YH; Gapin L; Berdyshev E; Wang CR
Front Immunol; 2020; 11():610010. PubMed ID: 33312179
[TBL] [Abstract][Full Text] [Related]
10. Slam haplotype 2 promotes NKT but suppresses Vγ4+ T-cell activation in coxsackievirus B3 infection leading to increased liver damage but reduced myocarditis.
Huber SA; Roberts B; Moussawi M; Boyson JE
Am J Pathol; 2013 Feb; 182(2):401-9. PubMed ID: 23195432
[TBL] [Abstract][Full Text] [Related]
11. The Janus Face of NKT Cell Function in Autoimmunity and Infectious Diseases.
Torina A; Guggino G; La Manna MP; Sireci G
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29389901
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-181a/b-1 Is Not Required for Innate γδ NKT Effector Cell Development.
Sandrock I; Ziętara N; Łyszkiewicz M; Oberdörfer L; Witzlau K; Krueger A; Prinz I
PLoS One; 2015; 10(12):e0145010. PubMed ID: 26673421
[TBL] [Abstract][Full Text] [Related]
13. NKT and tolerance.
Diana J; Beaudoin L; Gautron AS; Lehuen A
Methods Mol Biol; 2011; 677():193-206. PubMed ID: 20941612
[TBL] [Abstract][Full Text] [Related]
14. Benzofuran sulfonates and small self-lipid antigens activate type II NKT cells via CD1d.
Almeida CF; Smith DGM; Cheng TY; Harpur CM; Batleska E; Nguyen-Robertson CV; Nguyen T; Thelemann T; Reddiex SJJ; Li S; Eckle SBG; Van Rhijn I; Rossjohn J; Uldrich AP; Moody DB; Williams SJ; Pellicci DG; Godfrey DI
Proc Natl Acad Sci U S A; 2021 Aug; 118(34):. PubMed ID: 34417291
[TBL] [Abstract][Full Text] [Related]
15. Carbohydrate specificity of the recognition of diverse glycolipids by natural killer T cells.
Zajonc DM; Kronenberg M
Immunol Rev; 2009 Jul; 230(1):188-200. PubMed ID: 19594637
[TBL] [Abstract][Full Text] [Related]
16. Functions of CD1d-Restricted Invariant Natural Killer T Cells in Antimicrobial Immunity and Potential Applications for Infection Control.
Kinjo Y; Takatsuka S; Kitano N; Kawakubo S; Abe M; Ueno K; Miyazaki Y
Front Immunol; 2018; 9():1266. PubMed ID: 29928278
[TBL] [Abstract][Full Text] [Related]
17. Structural basis of NKT cell inhibition using the T-cell receptor-blocking anti-CD1d antibody 1B1.
Ying G; Wang J; Mallevaey T; Van Calenbergh S; Zajonc DM
J Biol Chem; 2019 Aug; 294(35):12947-12956. PubMed ID: 31296659
[TBL] [Abstract][Full Text] [Related]
18. Recognition of CD1d-restricted antigens by natural killer T cells.
Rossjohn J; Pellicci DG; Patel O; Gapin L; Godfrey DI
Nat Rev Immunol; 2012 Dec; 12(12):845-57. PubMed ID: 23154222
[TBL] [Abstract][Full Text] [Related]
19. CD1d-Restricted Type II NKT Cells Reactive With Endogenous Hydrophobic Peptides.
Nishioka Y; Masuda S; Tomaru U; Ishizu A
Front Immunol; 2018; 9():548. PubMed ID: 29599785
[TBL] [Abstract][Full Text] [Related]
20. CD4(+) type II NKT cells mediate ICOS and programmed death-1-dependent regulation of type 1 diabetes.
Kadri N; Korpos E; Gupta S; Briet C; Löfbom L; Yagita H; Lehuen A; Boitard C; Holmberg D; Sorokin L; Cardell SL
J Immunol; 2012 Apr; 188(7):3138-49. PubMed ID: 22371394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
